HIV-1 X4 Activities of Polycationic "Viologen" Based Dendrimers by Interaction with the Chemokine Receptor CXCR4: Study of Structure-Activity Relationship

被引:38
|
作者
Asaftei, Simona [1 ]
Huskens, Dana
Schols, Dominique [2 ]
机构
[1] Univ Osnabruck, Inst Chem, D-49069 Osnabruck, Germany
[2] Univ Louvain, Rega Inst Med Res, B-3000 Louvain, Belgium
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; FACTOR-I; CORECEPTOR; ENTRY; AMD3100; AGENTS; LIGAND; 7-TRANSMEMBRANE; LESTR/FUSIN; COMPLEXES;
D O I
10.1021/jm301337y
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of "viologen" based dendrimers with polycationic scaffold carrying 10, 18, 26, 42, and 90 charges per molecule were used to determine the structure-activity relationship (SAP.) with regard to HIV-1 inhibitory activity. The studies involved five compounds with a high activity against HIV-1 already utilized in our previous study(1) and five new dendrimers. Such dendrimers block HIV-1 entry into the cell, indicating that they bind to HIV-1 surface proteins and/or on the host cell receptors required for entry. The increasing positive character of dendrimers leads to more cytotoxicity. The 10 charges dendrimers (1, 6) have less influence on the cell viability but low inhibition of the binding of the CXCR4 mAb clone ID9. Thus, dendrimers with 18 charges (2, 7) are the most promising CXCR4 imaging probes. We report the design, synthesis, and biological activity of new HIV-1 inhibitors that are conceptually distinct from those of the existing HIV-1 inhibitors.
引用
收藏
页码:10405 / 10413
页数:9
相关论文
共 50 条
  • [1] Examination of Structure-Activity Relationship of Viologen-Based Dendrimers as CXCR4 Antagonists and Gene Carriers
    Li, Jing
    Lepadatu, Ana-Maria
    Zhu, Yu
    Ciobanu, Marius
    Wang, Yan
    Asaftei, Simona C.
    Oupicky, David
    BIOCONJUGATE CHEMISTRY, 2014, 25 (05) : 907 - 917
  • [2] Mycobacterium tuberculosis -: Induced CXCR4 and chemokine expression leads to preferential X4 HIV-1 replication in human macrophages
    Hoshino, Y
    Tse, DB
    Rochford, G
    Prabhakar, S
    Hoshino, S
    Chitkara, N
    Kuwabara, K
    Ching, E
    Raju, B
    Gold, JA
    Borkowsky, W
    Rom, WN
    Pine, R
    Weiden, M
    JOURNAL OF IMMUNOLOGY, 2004, 172 (10): : 6251 - 6258
  • [3] CXCR4 overexpression during the course of HIV-1 infection correlates with the emergence of X4 strains
    Lin, YL
    Portales, P
    Segondy, M
    Baillat, V
    de Boever, CM
    Le Moing, V
    Réant, B
    Montes, B
    Clot, J
    Reynes, J
    Corbeau, P
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 39 (05) : 530 - 536
  • [4] CD4-independent utilization of the CXCR4 chemokine receptor by HIV-1 and HIV-2
    Hoxie, JA
    LaBranche, CC
    Endres, MJ
    Turner, JD
    Berson, JF
    Doms, RW
    Matthews, TJ
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1998, 41 (1-2) : 197 - 211
  • [5] The Two Human CXCR4 Isoforms Display Different HIV Receptor Activities: Consequences for the Emergence of X4 Strains
    Duquenne, Charline
    Psomas, Christina
    Gimenez, Sandrine
    Guigues, Adeline
    Carles, Marie-Josee
    Barbuat, Claudine
    Lavigne, Jean-Philippe
    Sotto, Albert
    Reynes, Jacques
    Guglielmi, Paul
    Mettling, Clement
    Francois, Vincent
    Corbeau, Pierre
    JOURNAL OF IMMUNOLOGY, 2014, 193 (08): : 4188 - 4194
  • [6] Structure-activity relationship studies of a novel CXCR4 chemokine antagonist reveal unique activity profile
    Amela-Cortes, Celia
    Rezende, Martha
    Yakovleva, Tatyana
    Papa, Dan
    Perchellet, Elisabeth
    Perchellet, Jean-Pierre
    Vigil-Cruz, Sandra C.
    UNDERSTANDING BIOLOGY USING PEPTIDES, 2006, : 475 - +
  • [7] Structure-activity relationship studies of a novel CXCR4 chemokine antagonist reveal unique activity profile
    Amela-Cortés, C
    Rezende, M
    Yakovleva, T
    Perchellet, E
    Perchellet, JP
    Vigil-Cruz, SC
    BIOPOLYMERS, 2005, 80 (04) : 566 - 566
  • [8] Study of structure function correlation of chemokine receptor CXCR4
    郑红
    朱锡华
    Journal of Medical Colleges of PLA, 2002, (02) : 79 - 84
  • [9] Targeting Chemokine Receptor CXCR4 for Treatment of HIV-1 Infection, Tumor Progression, and Metastasis
    Choi, Won-Tak
    Yang, Yilei
    Xu, Yan
    An, Jing
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2014, 14 (13) : 1574 - 1589
  • [10] PEHMB may inhibit HIV-1 infection independently of the functions of the chemokine receptor CXCR4
    Thakkar, Nina
    Qian, Jin
    Schlipf, Lori
    Ferguson, Mary L.
    Miller, Shendra
    Kish-Catalone, Tina
    Wigdahl, Brian
    Labib, Mohamed
    Rando, Robert
    Krebs, Fred C.
    JOURNAL OF NEUROVIROLOGY, 2006, 12 : 80 - 81